Cite
HARVARD Citation
Ju, F. et al. (2022). Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade. Journal for immunotherapy of cancer. 10 (6), p. . [Online].